Satoris closes $1.1M for Alzheimer’s diagnostics
Satoris, a Redwood City, Calif. company that makes bloodstream-based diagnostic tests for Alzheimer’s disease, says it has raised $1.12 million toward an anticipated $1.5 million bridge round, which will be used to commercialize its lead product, reports VentureWire.
The plan is to market the tests to researchers and pharmaceutical companies as a precise way to track the progression of the disease. Eventually, the company says it will follow up with a clinical test — contingent on… Continue Reading
Satoris raises $5M, preps Alzheimer’s test for research use
Redwood City, Calif.-based Satoris, a biotech developing a blood test for Alzheimer’s disease, raised $5 million in a second funding round, VentureWire reports. The deal values Satoris at $13.8 million after the financings. The company had previously raised $1 million from individuals, and said it will seek another $15 million this year.
Satoris plans to use the funding to begin commercialization of its protein-based blood test for Alzheimer’s disease, which the company expects to make available… Continue Reading
Satoris seeks $5M for Alzheimer’s test — with high errors
Satoris, a Redwood City, Calif., biotech developing a diagnostic test for Alzheimer’s disease, is close to raising $5 million in a second funding round, VentureWire reports (subscription required). The funds will allow the company to make its test available to outside researchers.
Satoris made a big splash in mid-October, when researchers identified 18 proteins they said could be used to identify people with Alzheimer’s disease via a simple blood test. What’s more, the test also appeared… Continue Reading